Albemarle Corporation — Q1 2022 Form 10-Q Summary
Business context and reporting period
Albemarle is a global specialty chemicals producer operating through Lithium, Bromine and Catalysts segments. This unaudited Form 10-Q covers the three months ended March 31, 2022, compared with the three months ended March 31, 2021. The company reported strong lithium and bromine demand, while Catalysts performance was pressured by input and freight costs.
Key financial metrics
| Metric | Q1 2022 | Q1 2021 | Change |
|---|---|---|---|
| Net sales | $1.128 billion | $829.3 million | +36% |
| Gross profit | $449.0 million | $263.7 million | +70% |
| Gross margin | 39.8% | 31.8% | +8.0 pts |
| Operating profit | $312.0 million | $155.9 million | +100% |
| Net income attributable to Albemarle | $253.4 million | $95.7 million | +165% |
| Net margin | 22.5% | 11.5% | +11.0 pts |
| Diluted EPS | $2.15 | $0.84 | +156% |
| Adjusted EBITDA | $431.9 million | $230.1 million | +88% |
| Cash flow from operations | $206.2 million | $157.9 million | +31% |
Segment net sales were $550.3 million for Lithium, $359.6 million for Bromine and $217.9 million for Catalysts. Segment adjusted EBITDA was $308.6 million, $129.2 million and $16.9 million, respectively. Lithium benefited most from pricing and volume increases.
Cash and cash equivalents were $463.3 million at March 31, 2022, compared with $439.3 million at December 31, 2021. Capital expenditures were $231.7 million, and inventories increased to $1.014 billion from $812.9 million at year-end. Total debt was $2.489 billion, including $503.8 million due within one year and $1.986 billion classified as long-term debt. The company reported $1.28 billion of availability under its commercial paper program and credit agreements, plus $176.9 million under other lines of credit, subject to covenants.
Material changes versus the prior comparable period
- Sales growth was driven by $268.4 million of favorable pricing and $89.5 million of higher volume, partly offset by $49.6 million of sales lost following the June 2021 sale of the Fine Chemistry Services business and $9.9 million of unfavorable currency translation.
- Lithium sales increased 97% and adjusted EBITDA increased 190%, primarily from higher battery- and technology-grade pricing, increased tolling volume and stronger Talison joint-venture earnings.
- Bromine sales increased 28% and adjusted EBITDA increased 37%, supported by pricing and demand across products.
- Catalysts sales declined 1% and adjusted EBITDA declined 33%, reflecting lower volumes and higher natural gas, raw material and freight costs.
- Interest and financing expense declined to $27.8 million from $43.9 million. The 2022 amount included a $17.5 million correction of prior-period capitalized-interest errors; the 2021 amount included a $27.8 million loss on early debt extinguishment.
- The effective tax rate increased to 26.9% from 17.9%, primarily due to global intangible low-taxed income and changes in the geographic mix of earnings.
- Working-capital outflows increased as accounts receivable and inventory rose with higher sales and pricing. Cash generation nevertheless increased year over year.
Guidance, outlook, risks and unusual items
- Management expected Lithium results to be higher year over year in 2022, supported by pricing, new capacity in Chile and Australia, tolling arrangements, the planned Tianyuan acquisition and a strong EV and energy-storage market.
- Bromine sales and profitability were expected to be modestly higher, with pricing and productivity expected to offset higher freight and raw-material costs.
- Catalysts results were expected to be down 65% to flat year over year because of inflationary freight and input costs, including European natural-gas volatility associated with the war in Ukraine; higher refining-market pricing was expected to provide partial offset.
- 2022 capital expenditures were expected to be $1.3 billion to $1.5 billion, primarily for lithium growth and capacity expansion. Train II at Kemerton was expected to be completed in the second half of 2022, while the Tianyuan acquisition was expected to close in the third quarter, subject to customary conditions.
- The company expected cash on hand, operating cash flow, divestiture proceeds and borrowings to fund operations, debt service, capital expenditures, acquisitions, pension contributions and dividends for the foreseeable future. The quarterly dividend was increased to $0.395 per share.
- Material exposures include volatile lithium pricing, raw-material and energy costs, supply-chain and labor constraints, foreign exchange, interest rates, COVID-19 effects, geopolitical developments, environmental remediation and chemical-manufacturing hazards.
- Albemarle continued cooperating with the DOJ, SEC and Dutch Public Prosecutor regarding potential improper payments involving third-party sales representatives in its Refining Solutions business. The company could not predict the timing, scope, outcome or cost of the investigations.
- Recorded environmental liabilities were $48.1 million, with management estimating possible additional remediation costs of $10 million to $23 million before tax. The company also disclosed approximately $86.3 million of bank guarantees and letters of credit.
- The company settled the Huntsman arbitration for $665 million in two installments; the second and final payment was made in May 2022, after the quarter-end.
Most important facts for investors to verify
- Whether lithium pricing, volume growth and new capacity ramp-ups support management’s 2022 outlook.
- The timing and cost of Kemerton, La Negra, Silver Peak and Tianyuan projects, including any further supply-chain or labor delays.
- Whether Catalysts cost inflation and European natural-gas exposure remain within the stated outlook range.
- The effect of substantial planned capital expenditures and working-capital investment on free cash flow and leverage.
- The outcome and potential financial impact of the DOJ, SEC and Dutch investigations.
- Compliance with the 3.50:1 net funded debt-to-EBITDA covenant and the refinancing of short-term commercial paper.
- Potential additional environmental remediation costs and other litigation or indemnification obligations.